These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 8946932)
1. Regulation of the synthesis of bcl-2 protein by growth factors. Hu ZB; Minden MD; McCulloch EA Leukemia; 1996 Dec; 10(12):1925-9. PubMed ID: 8946932 [TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy. Hu ZB; Minden MD; McCulloch EA Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855 [TBL] [Abstract][Full Text] [Related]
3. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside. Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961 [TBL] [Abstract][Full Text] [Related]
4. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside. Yang GS; Minden MD; McCulloch EA Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841 [TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity. Koistinen P; Wang C; Curtis JE; McCulloch EA Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308 [TBL] [Abstract][Full Text] [Related]
8. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839 [TBL] [Abstract][Full Text] [Related]
9. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells. Hu ZB; Minden MD; McCulloch EA Leukemia; 1995 Oct; 9(10):1667-73. PubMed ID: 7564507 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1. McCrady CW; Li F; Pettit GR; Grant S Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503 [TBL] [Abstract][Full Text] [Related]
11. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells. te Boekhorst PA; Löwenberg B; Sonneveld P Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289 [TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. Bhalla K; Tang C; Ibrado AM; Grant S; Tourkina E; Holladay C; Hughes M; Mahoney ME; Huang Y Blood; 1992 Dec; 80(11):2883-90. PubMed ID: 1450413 [TBL] [Abstract][Full Text] [Related]
13. Enhanced proliferative activity of PIXY-321, the granulocyte-macrophage colony-stimulating factor and interleukin-3 fusion protein. Drexler HG; Meyer C Leuk Lymphoma; 1998 Mar; 29(1-2):119-28. PubMed ID: 9638981 [TBL] [Abstract][Full Text] [Related]
14. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines. Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401 [TBL] [Abstract][Full Text] [Related]
15. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. Yang GS; Minden MD; McCulloch EA Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996 [TBL] [Abstract][Full Text] [Related]
16. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2. Hedley DW; McCulloch EA Leukemia; 1996 Jul; 10(7):1143-9. PubMed ID: 8683994 [TBL] [Abstract][Full Text] [Related]
17. Effect of hemopoietic growth factors G-CSF and pIXY 321 on the activity of high dose Ara-C in human myeloid leukemia cells. Bhalla K; Tourkina E; Huang Y; Tang C; Mahoney ME; Ibrado AM Leuk Lymphoma; 1993; 10 Suppl():123-31. PubMed ID: 7683227 [TBL] [Abstract][Full Text] [Related]
18. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs. Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244 [TBL] [Abstract][Full Text] [Related]
19. Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor. Bradbury D; Zhu YM; Russell N Leukemia; 1994 May; 8(5):786-91. PubMed ID: 8182935 [TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia. Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]